1 – 10 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers
(
- Contribution to journal › Article
- 2022
-
Mark
Branching copy number evolution and parallel immune profiles across the regional tumor space of resected pancreatic cancer
(
- Contribution to journal › Article
-
Mark
High infiltration of CD68+/CD163- macrophages is an adverse prognostic factor after neoadjuvant chemotherapy in esophageal and gastric adenocarcinoma
(
- Contribution to journal › Article
- 2021
-
Mark
T cells, B cells, and PD-L1 expression in esophageal and gastric adenocarcinoma before and after neoadjuvant chemotherapy : relationship with histopathological response and survival
(
- Contribution to journal › Article
- 2020
-
Mark
Chemotherapy, host response and molecular dynamics in periampullary cancer : The CHAMP study
(
- Contribution to journal › Article
-
Mark
Quantitative, qualitative and spatial analysis of lymphocyte infiltration in periampullary and pancreatic adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Topographical Distribution and Spatial Interactions of Innate and Semi-Innate Immune Cells in Pancreatic and Other Periampullary Adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Tumor-Associated CD68+, CD163+, and MARCO+ Macrophages as Prognostic Biomarkers in Patients With Treatment-Naïve Gastroesophageal Adenocarcinoma
(
- Contribution to journal › Article
- 2019
-
Mark
Expression of PD-L1 and PD-1 in chemoradiotherapy-Naïve esophageal and gastric adenocarcinoma : Relationship with mismatch repair status and survival
(
- Contribution to journal › Article
-
Mark
Pre-diagnostic anthropometry, sex, and risk of colorectal cancer according to tumor immune cell composition
(
- Contribution to journal › Article